Active-ingredient Dossier
Betamethasone
Active-ingredient Dossier for Betamethasone (corticosteroid). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: BETNOVATE
- Brand: DIPROSONE
- Brand: DAIVOBET
- Brand: CALCIPOTRIOL/BETAMETHASONE
- Brand: ENSTILAR
- Brand: WYNZORA
- Therapeutic area: Dermatology
What is
Betamethasone Betamethasone is a corticosteroid.
Australian brands containing
Betamethasone — BETNOVATE — DAIVOBET — CALCIPOTRIOL/BETAMETHASONE — WYNZORA — BETAVANT — DIPROBET — DIPROVANT — NOVABET
Therapeutic areas
Betamethasone is registered in dermatology, with 9 brands containing this ingredient on the ARTG.
Sponsor landscape
Betamethasone is marketed by six sponsors: Nova Pharmaceuticals, Aspen Pharmacare, Sandoz, Actor Pharmaceuticals, LEO Pharma, and MC2 Therapeutics.
PBS and regulatory activity
One brand containing betamethasone has PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome for betamethasone was recorded on 1 March 2018, and the latest AusPAR was issued on 19 March 2013.